BioArctic's CEO Gunilla Osswald says in an interview that Novartis's withdrawal from the collaboration is not due to the company's technology. #Bioarctic #Novartis #Läkemedel (translated)
The Swiss pharmaceutical giant Novartis is terminating its collaboration and licensing agreement with the Swedish company Bioarctic, which could potentially have meant several billion kronor in revenue for the Swedish company. #Bioarctic #Novartis #Läkemedel (translated)
Bioarctic announces that sales of the drug Leqembi in the third quarter amounted to 32.2 billion yen. #Bioarctic #Läkemedel #Marknadsnytt (translated)
Bioarctics partner Eisai presenterade på AAIC 2026 nya data som visar att den subkutana autoinjektorformuleringen av Leqembi erbjuder likvärdig effekt och säkerhet som intravenös behandling för patienter med tidig Alzheimers sjukdom. #Bioarctic #Alzheimers #Läkemedel
